Table 3.
Factors associated with preference of HPV vaccine (N = 3586)
| Frequency (%) | Univariate analysis | Multivariable logistic regression | |||||
|---|---|---|---|---|---|---|---|
| Preference of HPV vaccine | p-value | Imported vs Local/Don’t mind | |||||
| Imported n = 2019 |
Local/Don’t mind n = 1567 |
OR (95% CI) | |||||
| Mother’s information | |||||||
| Age group (years old) | |||||||
| 23-35 | 1699 (47.4) | 1012 (59.6) | 687 (40.4) | 1.323 (1.090–1.607)** | |||
| 36-40 | 1292 (36.0) | 706 (54.6) | 586 (45.4) | p < .001 | 1.106 (0.906–1.349) | ||
| >40 | 595 (16.6) | 301 (50.6) | 294 (49.4) | Reference | |||
| Birthplace | |||||||
| Urban | 587 (16.4) | 363 (61.8) | 224 (38.2) | 0.003 | 1.256 (1.041–1.516)* | ||
| Rural | 2999 (83.6) | 1656 (55.2) | 1343 (44.8) | Reference | |||
| Working location | |||||||
| Urban | 1793 (50.0) | 1039 (57.9) | 754 (42.1) | 0.051 | |||
| Rural | 1793 (50.0) | 980 (54.7) | 813 (45.3) | ||||
| Marital Status | |||||||
| Married | 3406 (95.0) | 1915 (56.2) | 1491 (43.8) | 0.701 | |||
| Unmarried/Divorced/ Separated/Widowed |
180 (5.0) | 104 (57.8) | 76 (42.2) | ||||
| Highest education level | |||||||
| Primary school and below | 223 (6.2) | 97 (43.5) | 126 (56.5) | Reference | |||
| Secondary school | 2026 (56.5) | 1131 (55.8) | 895 (44.2) | p < .001 | 1.436 (1.077–1.913)* | ||
| High school/technical secondary school | 982 (27.4) | 591 (60.2) | 391 (39.8) | 1.558 (1.145–2.121)** | |||
| University and above | 355 (9.9) | 200 (56.3) | 155 (43.7) | 1.242 (0.868–1.777) | |||
| Occupational types | |||||||
| Professional and managerial | 233 (6.5) | 132 (56.7) | 101 (43.3) | ||||
| General office worker/Service personnel | 499 (13.9) | 292 (58.5) | 207 (41.5) | ||||
| Industrial worker/Farmers/Others | 1274 (35.5) | 682 (53.3) | 592 (46.5) | 0.067 | |||
| Individual business/Self-employed | 625 (17.4) | 376 (60.2) | 249 (39.8) | ||||
| Housewife/Unemployed | 955 (26.6) | 537 (56.2) | 418 (43.8 | ||||
| Annual household income (RMB) | |||||||
| <50,000 | 1976 (55.1) | 1051 (53.2) | 925 (46.8) | Reference | |||
| 50,000–120,000 | 1610 (44.9) | 748 (58.7) | 526 (41.3) | p < .001 | 1.189 (1.026–1.377)* | ||
| >120,000 | 336 (9.4) | 220 (65.5) | 116 (34.5) | 1.566 (1.219–2.012)*** | |||
| Experience with cervical cancer | |||||||
| Ever known anyone has had cervical cancer | |||||||
| Yes | 705 (19.7) | 394 (55.9) | 311 (44.1) | 0.832 | |||
| No | 2881 (80.3) | 1625 (56.4) | 1256 (43.6) | ||||
| Daughter’s information | |||||||
| Age (years old) | |||||||
| 6-8 | 858 (23.9) | 500 (58.3) | 358 (41.7) | ||||
| 9-11 | 1489 (41.5) | 848 (57.0) | 641 (43.0) | 0.140 | |||
| 12-14 | 1239 (34.6) | 671 (54.2) | 568 (45.8) | ||||
| Had chronic illnesses | |||||||
| Yes | 80 (2.2) | 43 (53.8) | 37 (46.2) | 0.650 | |||
| No | 3506 (97.8) | 1976 (56.4) | 1530 (43.6) | ||||
| Ever experienced serious side effects in any previous vaccinations | |||||||
| Yes | 326 (9.1) | 179 (54.9) | 147 (45.1) | 0.599 | |||
| No | 3260 (90.9) | 1840 (56.4) | 1420 (43.6) | ||||
*p < 0.05, **p < 0.01, ***p < 0.001
aHosmer & Lemeshow test, chi-square:17.950, p-value: 0.012; Nagelkerke R2: 0.020